Comparison of figure-of-8 and circular coils for threshold tracking transcranial magnetic stimulation measurements.

Circular coil Figure-of-8 coil SICI Short interval intracortical inhibition TMS Threshold tracking Transcranial magnetic stimulation

Journal

Neurophysiologie clinique = Clinical neurophysiology
ISSN: 1769-7131
Titre abrégé: Neurophysiol Clin
Pays: France
ID NLM: 8804532

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 09 11 2020
revised: 05 01 2021
accepted: 05 01 2021
pubmed: 21 1 2021
medline: 18 9 2021
entrez: 20 1 2021
Statut: ppublish

Résumé

The transcranial magnetic stimulation (TMS) technique of threshold-tracking short-interval intracortical inhibition (T-SICI) has been proposed as a diagnostic tool for amyotrophic lateral sclerosis (ALS). Most of these studies have used a circular coil, whereas a figure-of-8 coil is usually recommended for paired-pulse TMS measurements. The aim of this study was to compare figure-of-8 and circular coils for T-SICI in the upper limb, with special attention to reproducibility, and the pain or discomfort experienced by the subjects. Twenty healthy subjects (aged: 45.5 ± 6.7, mean ± SD, 9 females, 11 males) underwent two examinations with each coil, in morning and afternoon sessions on the same day, with T-SICI measured at interstimulus intervals (ISIs) from 1-7 ms. After each examination the subjects rated degree of pain/discomfort from 0 to 10 using a numerical rating scale (NRS). Mean T-SICI was higher for the figure-of-8 than for the circular coil at ISI of 2 ms (p < 0.05) but did not differ at other ISIs. Intra-subject variability did not differ between coils, but mean inhibition from 1-3.5 ms was less variable between subjects with the figure-of-8 coil (SD 7.2% vs. 11.2% RMT, p < 0.05), and no such recordings were without inhibition (vs. 6 with the circular coil). The subjects experienced less pain/discomfort with the figure-of-8 coil (mean NRS: 1.9 ± 1.28 vs 2.8 ± 1.60, p < 0.005). The figure-of-8 coil may have better applicability in patients, due to the lower incidence of lack of inhibition in healthy subjects, and the lower experience of pain or discomfort.

Identifiants

pubmed: 33468370
pii: S0987-7053(21)00002-2
doi: 10.1016/j.neucli.2021.01.001
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

153-160

Subventions

Organisme : Medical Research Council
ID : MR/K015222/1
Pays : United Kingdom

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

Søren Ørskov (S)

Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark.

Hugh Bostock (H)

Department of Clinical Neurophysiology, National Hospital for Neurology and Neurosurgery, Queen Square, WC1N 3BG, London, United Kingdom.

James Howells (J)

Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

Kirsten Pugdahl (K)

Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark.

Anders Fuglsang-Frederiksen (A)

Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark.

Christina Shen-Zhuang Nielsen (CS)

Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark.

Bülent Cengiz (B)

Department of Neurology, Gazi University Faculty of Medicine, Beşevler, 06500, Ankara, Turkey.

Gintaute Samusyte (G)

Department of Neurology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Martin Koltzenburg (M)

Department of Clinical Neurophysiology, National Hospital for Neurology and Neurosurgery, Queen Square, WC1N 3BG, London, United Kingdom; Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, WC1N 3BG, London, United Kingdom.

Hatice Tankisi (H)

Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: hatitank@rm.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH